WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Wraps Up 2025 Drug Negotiation: Dual Catalogs Debut, Innovative Drug Cut... From October 30 to November 3, China's 2025 National Reimbursement Drug Negotiations officially concluded after five days of talks — marking the first time that the coun...
(11/5/2025)

Innovative Antibody Therapeutic Development in... (11/13/2025)

China Wraps Up 2025 Drug Negotiation: Dual Cat... (11/5/2025)

MNCs Retreat as China Cancels Dozens of Brande... (11/5/2025)

Bloomberg: China Has Another Trade Weapon Wait... (11/5/2025)

China's Biotech Deal Boom Tests Ethical Bounda... (10/31/2025)

China Pushes Ethical Limits in Global Biotech ... (10/29/2025)

Understanding China's Longevity Market: Indust... (10/22/2025)

ESMO 2025 Highlights China's Strategic Leap in... (10/21/2025)

Novo vs. KBP: Fraud or Due Diligence Slipup? (... (10/17/2025)

First Drug Patent Term Extension Granted In Ch... (10/13/2025)

U.S. Senate Approves Revised China Biotech Com... (10/13/2025)

China's Innovative Drug Sector Secures Over CN... (10/13/2025)

WuXi AppTec Establishes European Headqua... (11/13/2025) Alcon Expands China Strategy with Focus ... (11/13/2025) Global Pharma and Biotech Leaders Announ... (11/13/2025) Biokin Postpones Planned Hong Kong IPO A... (11/13/2025) GenFleet Registers First Phase 3 Trial o... (11/13/2025) Groovy Secures Series A Financing to Adv... (11/13/2025) Kind Pharma Secures Over CNY 400M in S... (11/13/2025) InSilico Files for Hong Kong IPO to Acce... (11/13/2025) Kexing Biopharm Files for Hong Kong IPO ... (11/13/2025) Laekna Grants Qilu Pharma Exclusive Grea... (11/13/2025) Indian Pharma Firms Secure Key Wins in C... (11/12/2025) BeOne Launches Global Phase 1 Trial of F... (11/12/2025) Rona Thera Unveils Promising Phase 1 Dat... (11/12/2025) Lyell Acquires Global Rights to ICT's Ne... (11/12/2025) Brise Secures Over CNY 200M Series A to ... (11/12/2025) Aureka Closes Multi-Million-Dollar Serie... (11/12/2025) DeliNova Raises CNY 60 Million in Seed a... (11/12/2025) Brightintel Secures Multi-Million CNY Se... (11/12/2025)

China's Aging Population to Drive Trillion-Dollar Healt... China's Innovative Drug Market Shows Diverging Trends B... Innovent's Weight-Loss Drug Challenges Western Giants i... China's PD-(L)1 Market Shows Continued Growth in H1 202... China to Become World's Third-Largest Innovative Drug M...

Laekna Grants Qilu Pharma Exclusive Greater China Right... Kexing Biopharm Files for Hong Kong IPO to Advance Biol... InSilico Files for Hong Kong IPO to Accelerate AI-Drive... Kind Pharma Secures Over CNY 400M in Series C Financi... Groovy Secures Series A Financing to Advance AI-Driven ...

CDE Opens Public Consultation on Draft Guidelines for R... CDE Reopens Consultation on Influenza Vaccine Clinical ... CDE Issues Technical Guidelines for Pharmaceutical Rese... NMPA Pilots Streamlined Review Pathway for Supplemental... CDE Seeks Comments on the 100th Batch of Reference Form...

China Launches National Strategy to Integrate AI Across... China to Expand Use of Artificial Intelligence Across H... China Expands Drug Access Through 11th National Bulk-Bu... China to Include HPV Vaccines in National Immunization ... China's BMI Fund Maintains Strong Surplus in First Thre...

BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ... SAMR Orders Simcere to Reverse Unnotified Merger Over C...

Clariant Completes Expansion of Pharma Excipients and S... Sanofi Launches €1B Insulin API Manufacturing Project ... China Faces New Pressure as U.S. Eyes Middle East for D... FDA Issues Warning to Chengdu Biopharma Over cGMP Viola... China's Sharp API Price Cuts Jeopardize India's Self-Re...

GenFleet Registers First Phase 3 Trial of KRAS G12D Inh... Huahui to Present 48-Week Phase 2b Data of Libevitug at... Innovent and SanegeneBio Present Positive Phase 1 Data ... Summit and Akeso Report Positive Phase III Results for ... China Approves CPEB's Pediatric CAR‑T Therapy for r/r ...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Senior CSPC Executive Fined CNY 5M for Insider Trading Recent Executive Moves Recent Executive Moves Recent Official and Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...